Thromboxane biosynthesis and future events in diabetes: the ASCEND trial.
Giovanna PetrucciGeorgina A BuckBianca RoccaSarah ParishColin BaigentDuaa HatemMarion M MafhamAida HabibLouise BowmanJane ArmitageCarlo PatronoPublished in: European heart journal (2024)
The U-TXM was log-linearly independently associated with SVE-R in diabetes. This is consistent with the involvement of platelet TXA2 in diabetic atherothrombosis.